China Biotech Services (08037) signs a memorandum of understanding on cooperation in Boron Neutron Therapy medical insurance products.

Zhixin Finance APP News, China Biotechnology Services (08037) announced that on July 10, 2025, the company, AXA Anchon Insurance (Bermuda) Limited (AXA ANCHOR Hong Kong), a limited company registered in Bermuda, and AXA Globe Reinsurance (Shanghai) Limited (AXA Globe Reinsurance, together with AXA ANCHOR Hong Kong, collectively referred to as "AXA ANCHOR"), Qianhai Reinsurance Co., Ltd. (Qianhai Reinsurance) and Arthur J. Gallagher (Singapore) Pte. Ltd. (Arther J. Gallagher) have signed a non-legally binding memorandum of understanding regarding the cooperation to jointly develop an inclusive medical insurance product for boron neutron capture therapy (BNCT) treatment costs and related services.